The historic Mount Tambora volcanic eruption spewed so much ash and debris that it triggered a "year without summer" and the ...

Strong Q1 2025 for Alphatec Holdings: 22% revenue growth, adjusted EBITDA raised to $78M, and cash flow positivity goals reaffirmed.

Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its senior management team will participate in the following upcoming investor conferences: H.C. Wainwright Royalty Company ...

The company has a "first-mover advantage" when it comes to investing in Bitcoin, and its decision to retain all of the ...

Fintel reports that on April 29, 2025, HC Wainwright & Co. initiated coverage of MicroStrategy Incorporated - Preferred Stock (NasdaqGS:STRK) with a Buy recommendation. Analyst Price Forecast Suggests ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $59.57, with a ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

Novocure (NVCR) recognized first non-small cell lung cancer revenues ahead of schedule, with 92 Optune Lua prescriptions for NSCLC received in ...

H.C. Wainwright reiterates a Buy rating and $12 price target on shares of Orchestra BioMed (OBIO) after the company announced that the Food and ...

All shares of common stock and pre-funded warrants to be sold in the offering will be offered by Rezolute. The closing of the offering is expected to occur on or about April 24, 2025, subject to the ...

Fintel reports that on April 23, 2025, HC Wainwright & Co. initiated coverage of Oklo (NYSE:OKLO) with a Buy recommendation.

H.C. Wainwright says the bar is set for oral GLP-1s following this morning’s type 2 diabetes data from Eli Lilly (LLY). The firm continues to expect Viking Therapeutics (VKTX) to ...